CD8A and diffuse large B-cell lymphoma: SNHG14/miR-5590-3p/ZEB act as a positive feedback loop in diffuse large B-cell lymphoma (DLBCL) cells to activate PD-L1, thereby inactivating CD8 + T cells and enhancing immune evasion.